UCA1 is upregulated in the tumours of NSCLC patients with acquired resistance to the EGFR-TKI gefitinib, but lacking the T790M mutation, compared to levels prior to gefitinib treatment. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.